Masitinib mesylate for metastatic and non‐resectable canine cutaneous mast cell tumours

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5829|13|3|314-321

ISSN： 1476-5810

Source： VETERINARY AND COMPARATIVE ONCOLOGY, Vol.13, Iss.3, 2015-09, pp. : 314-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 2, 2015-06 ,pp. : 143-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apoptotic intrinsic pathway proteins predict survival in canine cutaneous mast cell tumours

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : E38-E44

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of histologic margin status in low‐grade cutaneous and subcutaneous canine mast cell tumours examined by radial and tangential sections

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : 125-130

John Wiley & Sons Inc

Access to resources Recommend Favorite

The value of molecular expression of KIT and KIT ligand analysed using real‐time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 1, 2015-03 ,pp. : 1-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of histological grade and histologically tumour‐free margins as predictors of local recurrence in completely excised canine mast cell tumours

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 1, 2015-03 ,pp. : 70-76

John Wiley & Sons Inc

Access to resources Recommend Favorite